NeuroLight, Inc.

01/16/2024

https://neurolight.co/us-patent-granted-to-neurolight-for-technology-to-induce-sleep-by-neuromodulation/

POMONA, NEW YORK, USA, January 11, 2024 -- NeuroLight, Inc., a leading innovator in the field of neuromodulation, is thrilled to announce the recent grant of

08/16/2023

https://www.prweb.com/releases/2023/08/prweb19483093.htm #

POMONA, N.Y. (PRWEB) August 10, 2023 -- NeuroLight, Inc., a neuromodulation company, announced that it was awarded a US patent on the technology to enhance...

03/21/2023

Attention insomniacs and sleep medicine practitioners:

If you have personally experienced insomnia and are interested in contributing to the development of potential solutions that could help you, or if you are a sleep medicine or primary care physician, we would love to hear from you. Your experience and insights would be incredibly valuable to our research for a proposed solution to better sleep.

The interview will take place virtually via video conferencing and is expected to last no more than 15 minutes. Your participation is voluntary, and all information will be kept strictly confidential.

NeuroLight, is a sleep technology company, funded by the National Sciences Foundation and an SBIR grant. We are conducting this research to gain insights into the challenges and needs of individuals suffering from insomnia and to develop innovative technology solutions for improving sleep.

If you are interested in participating in an interview, please drop us a message or contact me at Alex@NeuroLightco. I look forward to speaking with you soon.

03/21/2023

11/23/2022

https://www.healthleadersmedia.com/innovation/can-brain-waves-be-harvested-treat-sleep-disorders

A New York company has received a federal grant to test a digital health platform that captures brainwaves from a healthy sleeper and transplants them into someone with a sleeping disorder.

11/15/2022

NeuroLight Awarded Competitive Grant from the U.S. National Science Foundation

R&D Funding Accelerates Proof-of-Concept Prototype Development

Suffern, N.Y., November 15, 2022—NeuroLight, Inc. (f.k.a. Neuroenhancement Lab, LLC), a Suffern, New York-based neuromodulation company, today announced that it has been awarded a U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,851 to conduct research and development (R&D) work on a neuromodulation device to promote healthy sleep.

Sleep deprivation is a silent pandemic. In fact, seven of the 15 leading causes of death in the U.S. have been linked to sleep deprivation. Neuromodulation — stimulating the brain using light and sound — promises to offer a noninvasive, nonpharmaceutical alternative to help the millions who suffer with sleep disorders.

NeuroLight is the first company to develop technology for transplanting mental states™ from one person to another. The company intends to use this approach to promote healthy sleep by recording brainwaves in a healthy sleeping person and reproducing the same brain rhythms in another subject who struggles with sleep. The science behind this revolutionary technology was published in the peer-reviewed journal, Frontiers in Human Neuroscience (9/22/2021).

“We are honored and gratified to have been awarded this highly competitive grant by the NSF,” said NeuroLight Founder and President Alexander Poltorak. “This grant will support R&D efforts to develop a prototype for the proof-of-concept study.”

All proposals submitted to the NSF SBIR/STTR program, also known as America’s Seed Fund powered by NSF, undergo a rigorous merit-based review process. Once a small business is awarded a Phase I grant, it becomes eligible to apply for Phase II funding and additional supplements totaling up to $1.7 million.

About NeuroLight, Inc.

NeuroLight, Inc. (f.k.a. Neuroenhancement Lab, LLC) is a neuromodulation R&D company developing pioneering technology for transplanting mental states™ from one person to another. The first application the company is working on is the potential treatment of insomnia For more information, visit the company’s website at www.NeuroLight.co.

About the U.S. National Science Foundation’s Small Business Programs.

America’s Seed Fund powered by NSF awards more than $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. The NSF is an independent federal agency that supports fundamental research and education across all fields of science and engineering. To learn more about America’s Seed Fund powered by NSF, visit: https://seedfund.nsf.gov/

# # #

Summary: NeuroLight, Inc., a neuromodulation company first to develop technology for transplanting mental states™, awarded grant from the U.S. National Science Foundation (NSF)

Keywords: ,

11/15/2022

Neuroenhancement Lab, Inc. Announces Rebrand as NeuroLight
New Name Reflects Use of Light for Brain Entrainment

Suffern, N.Y., October 25, 2022—Neuroenhancement Lab, Inc., a Suffern, New York-based neuromodulation company, today announced that it had completed a major rebranding. The new name, NeuroLight, reflects the shift from using transcranial electric stimulation of the brain toward using light as the primary modality for neurostimulation, brain entrainment, and photobiomodulation.

NeuroLight is the first company to develop technology for transplanting mental states™ from one person to another. A pilot study done in collaboration with the Neuromodulation Lab at the City College of New York (CCNY/CUNY), used proprietary transcranial electric stimulation (TES) to induce sleep in volunteer subjects with promising results. Subsequent research identified light and sound as ideal stimuli for brain entrainment. This emphasis on light prompted the rebranding.

“Further research led us to identify light and sound as ideal stimuli for brain entrainment,” said NeuroLight Founder and President Alexander Poltorak. “This emphasis on light is taking us in new directions and prompted our rebranding and new name.”

The human brain is naturally entrained by sunlight light, which stimulates photosensitive cells in the retina, signaling the brain to synchronize the endogenous circadian rhythms to local time and day/night cycles. Rhythmic music causes us to instinctively clap hands, tap our feet, or move our bodies in sync with the beat.

NeuroLight aims to harness the science of transplanting brain states to help users achieve their desired brain states. For example, the technology may help improve the quality of sleep by recording brain states associated with various stages of sleep in healthy sleepers and then reproducing those states in the brains of people who struggle to achieve quality sleep through neuromodulation using light (photobiomodulation) and sound.

“The company’s proprietary technology could help people achieve not only better sleep but also higher concentration and performance,” Poltorak said.

Besides the new name, NeuroLight, this rebranding effort includes a new logo and website—www.NeuroLight.co.

About NeuroLight, Inc.

NeuroLight, Inc. is a neuromodulation R&D company developing pioneering technology for transplanting mental states™ from one person to another (or the same person at a different time). Mental states are represented in the brain by their neural correlates—brainwaves. Transplanting a mental state from a donor to a recipient entails recording brainwaves of the donor while in a desired mental state and then stimulating the brain of the recipient with a waveform extracted from the donor’s brainwaves to induce the desired mental state. Besides photobiomodulation using light, NeuroLight also uses auditory stimulation in the form of binaural beats or isochronic tones. The first application the company is working on is the potential treatment of insomnia by entraining a patient’s brain with visual and auditory stimuli modulated with a naturalistic waveform derived from endogenous brainwaves of the sleeping donor. This technology is the subject of numerous patent applications. For more information, visit the company’s website at www.NeuroLight.co.

# # #

Summary: Neuroenhancement Lab, Inc., a neuromodulation company first to develop technology for transplanting mental states™ from one person to another, rebrands itself as NeuroLight.

Keywords: , ,